Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Boart Longyear Releases an Upgraded Surface Roller Latch Head Assembly and Overshot 2023-11-01 01:30
Technicolor Creative Studios selects Cognizant as its IT & Digital Transformation Partner 2023-10-31 22:06
CANACCORD GENUITY GROUP INC. ACCESS TO SECOND QUARTER FISCAL 2024 RESULTS INFORMATION 2023-10-31 21:51
Aker Horizons allocated grid capacity for green ammonia production in Narvik and Berlevåg by Statnett 2023-10-31 21:15
GCLSI Reports Impressive Growth for First Three Quarters, Net Profit Surges 240% YoY 2023-10-31 21:07
Patriot Expands its Land Position at its Eastmain Project in the Eeyou Istchee James Bay Region, Quebec 2023-10-31 21:00
BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures 2023-10-31 21:00
YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-10-31 20:30
iba 2023: Angel Yeast brings latest baking products and solutions, empowering the China team to triumph in the iba.UIBC.Cup of Bakers 2023-10-31 20:00
Johnson Controls Recognised for Equipping Local Workforce with Skills for the Built Environment 2023-10-31 18:25
IFS delivers strong Q3 2023 results thanks to increased demand for AI 2023-10-31 17:48
MINISO Opens Three New Stores in Hong Kong as Part of Ongoing Global Expansion 2023-10-31 16:33
GomSpace receives order for cutting-edge products from diverse customers at a total value of €923.000 (approx. 10.8MSEK) 2023-10-31 16:29
H World Attends Hotel Investment Conference Asia Pacific 2023 2023-10-31 15:45
Clarivate Report Reveals China Challenging U.S. Research Dominance, Signaling Future Research Ambitions 2023-10-31 15:00
VIETJET REACHES 95% ANNUAL REVENUE TARGET, RECEIVES US$100 MILLION FROM INVESTMENT FUNDS IN Q3/2023 2023-10-31 11:06
UOB makes steady progress on net zero commitment 2023-10-31 10:32
CStone Announces NMPA Approval of Sugemalimab for Patients with Relapsed or Refractory Extranodal NK/T-cell Lymphoma, the First Anti-PD-1/PD-L1 mAb Approved for this Indication 2023-10-31 10:16
AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery 2023-10-31 09:35
Amorepacific Incorporates COSRX as a Subsidiary through Additional Stake Acquisition 2023-10-31 08:00
1 185 186 187 188 189 1175